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Abstract
Nucleo-cytoplasmic transport of RNA is one of many cellular pathways whose illumination has
progressed hand in hand with understanding of retroviral mechanisms. A recent paper in Cell
reports the involvement of an RNA helicase in the pathway by which HIV exports partially spliced
and unspliced RNA out of the nucleus. This suggests the ubiquity of RNA helicases in RNA export
from the nucleus, and has novel mechanistic implications.
HIV must export to the cytoplasm not only full length
genomic and structural gene-encoding RNA species, but
also partially and fully spliced RNAs which code for a vari-
ety of overlapping structural and accessory genes. Whereas
the fully spliced HIV RNA species readily exit the nucleus
and undergo translation, the partially spliced and
unspliced species require the interaction of the HIV-1 Rev
protein with the cis-acting, viral RRE (Rev responsive ele-
ment) for expression. Simpler retroviruses, such as the
type-D Mason-Pfizer monkey virus (MPMV) solve a simi-
lar problem by encoding a cis-acting, constitutively active
CTE (constitutive transporter element) in the 3'UTR of the
viral genome, which uses a distinct pathway [1,2]. Of less
clear significance is the existence of CRM-1 dependent
nuclear export signals in gag proteins of HIV and RSV. It is
theoretical possibility that shuttling gag proteins might
contribute to nucleocytoplasmic export of genomic RNA,
but it is equally possible that the only need for nuclear
export of gag is to overcome the nuclear targeting signals
late in viral replication [3,4]. Over the last seven years or
so, tremendous progress has been made in characterizing
nucleocytoplasmic transport pathways.
The Rev/RRE pathway involves the Ran-CRM-1, shuttling
system: In the nucleus, Ran-GEF converts Ran-GDP to
Ran-GTP. Ran-GTP bound CRM-1 binds the NES (nuclear
export signal) domain of Rev, which is in turn bound to
the RRE, and enables CRM-1 to transport the resulting
RNA/protein complex as cargo into the cytoplasm, pre-
sumably through CRM-1 interactions with nucleoporins.
In the cytoplasm, Ran-GAP converts Ran-GTP to Ran-
GDP, releasing the REV/RNA cargo. The asymmetric distri-
bution of Ran-GEF and Ran-GAP between nucleus and
cytoplasm ensures a constant RAN-GTP/GDP gradient to
facilitate CRM-1 recycling and continued Rev/RRE export.
CTE-mediated RNA export is based on binding to the Tap-
NXT complex, and export through an unrelated transport
pathway, which, ironically, is responsible for the bulk of
mRNA transport [2].
Enter the laboratories of Kuan-Teh Jeang and Larry Klei-
man, who, in a comprehensive study in the October 29th
issue of Cell, report the involvement of the RNA helicase,
DDX3, in the Rev/RRE pathway [5]. Interestingly, DDX3
attracted their attention in preliminary screens indicating
it was upregulated by the HIV-1 Tat protein, which is
directly involved in transcriptional, not post-transcrip-
tional regulation. Studying the effects of DDX3 overex-
pression, expression of dominant negative DDX3
mutants, or antisense knockdown of DDX3, variously on
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expression of Rev/RRE dependent reporter genes, Rev/RRE
dependent subgenomic HIV constructs, or full length HIV
genomes, Yedavalli et al. determined that in all cases,
DDX3 had effects consistent with its playing a significant
role in Rev/RRE dependent expression. These effects
included expression of proteins, and nucleocytoplasmic
partitioning of Rev/RRE dependent and Rev/RRE inde-
pendent RNAs. In parallel studies, they determined that
DDX3 had no effect on expression from CTE dependent
constructs.
A number of findings not only provided evidence consist-
ent with a role for DDX3 in the Rev export pathway, but
also provided mechanistic insights. DDX3, though consti-
tutively cytoplasmic, shuttles between nucleus and cyto-
plasm in a manner dependent on CRM-1, as evidenced by
inhibition by leptomycin B (LMB), which inhibits CRM-1
export, but not Tap export. DDX3 also localizes to nuclear
outer membranes in a speckle formation and co-immuno-
precipitates with nucleoporins, in addition to having a
distribution in the cytoplasm. In cell lysates, DDX3 co-
immunoprecipitates with either Rev protein or CRM-1.
Although the studies on cell lysates fail to distinguish
between pairwise binding and ternary complex forma-
tion, ternary complex formation is a distinct possibility.
DDX3 directly binds CRM-1 in vitro (in a manner inde-
pendent of its NES). Although no data are presented con-
cerning direct in vitro binding of DDX3 to Rev, for such an
interaction to exist and to be significant, DDX3 would
have to bind one of the three identified functional regions
in Rev. These include the NES, the coincident NLS/RBD
(nuclear localization signal/RNA binding domain) and
the Rev multimerization domain, which flanks the RBD
[6]. No regions in Rev besides these have been identified
by mutagenesis or by any other techniques to be critical
for function. Such an interaction would seem unlikely
(though not impossible) in a complex of oligomerized
Rev bound to RNA and CRM-1. Conceptually it might be
easier to accommodate all the binding interactions in
some kind of "pass-along" mechanism. This could allow
some of the binding interactions to take place sequen-
tially, rather than simultaneously.
In the tradition of good research, the results of Yedavalli
et al. [5] pose as many questions as they answer. Though
the binding interactions so far discovered, and DDX3's
ability to shuttle between nucleus and cytoplasm could be
consistent with a quarternary complex of Rev, RNA, CRM-
1 and DDX3, the existence of such a complex remains to
be proven (and the authors avoid implying its existence).
It is possible there is some sort of "pass along" mechanism
in which some of the binding interactions are sequential.
It is tempting to suggest that DDX3 plays a role in reliev-
ing torsional tension to facilitate RNA passage through a
confining nuclear pore, or that it helps remove certain
proteins from RNA before, as, or after it reaches the cyto-
plasmic side of the nuclear membrane. Two other heli-
cases have been implicated in RNA nuclear export
pathways. In yeast, Dbp5p helicase, binds nucleoporins,
localizes to nuclear pore complexes on the cytoplasmic
side of the nuclear membrane, and is involved in mRNA
export [7-9]. RNA helicase A (RHA) has been implicated
in CTE-mediated transport [10-13]. A general requirement
for RNA helicases in RNA transport is an attractive con-
cept. Conceivably they could even be a significant molec-
ular motor contributing to RNA transport: some RNA
helicases are highly processive [see [14] and references
therein] and may work by translocating along ssRNA, dis-
placing bound RNA and protein (the "snowplow"
model). At least one highly processive RNA helicase has
been show to displace tightly bound protein from dsRNA
[15]. An energy-dependent, highly processive RNA heli-
case tethered to the cytoplasmic side of the nucleopore
could thus pull a long RNA molecule through the pore
(see Figure 1). Theoretically this could solve the problem
of how to get the rest of the RNA through the pore once
the region initially targeted by CRM-1 (the RRE in the case
of HIV) is transported and released. Other possibilities
could, of course, include other molecular motors such as
kinesin, in association with protein/RNA complexes [16].
On a highly speculative note, the intimate involvement of
a DEAD box helicase in the Rev pathway, and the observa-
tion that DDX3 has a cytoplasmic localization, in addi-
tion to its nuclear membrane localization, recalls some
old data from two independent laboratories, indicating
that in some systems Rev may not act on export, but on
post export events, to promote Rev/RRE dependent
expression [17,18]. The eIF4A family has been called the
"godfather" of DEAD box helicases [19]. EIF4A3 can be
targeted to the exon junction complex of spliced mRNA,
and it has been speculated that it may have a splicing-
dependent influence on mRNA translation [20]. In cell
types where Rev does not act through export, could it act
by specifically targeting to the ribosome a related DEAD
box RNA helicase, translation initiation factor? Time will
tell.
Finally there is the possibility that specific helicases will
be valid therapeutic targets for antiretroviral chemother-
apy. Although targeting a cellular gene involved in a viral
pathway risks inhibiting a necessary cellular function, it
avoids the overwhelming problem posed by rapid viral
mutation to resistance.
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Schematic diagram outlining Rev mediated RNA export from nucleus to cytoplasm Figure 1
Schematic diagram outlining Rev mediated RNA export from nucleus to cytoplasm. a, Viral RNA develops secondary structure 
before binding critical protein components of the export pathway. b, Rev protein binds the RRE, forming a complex of REV, 
viral RNA, CRM-1 and DDX3, which begins to unwind secondary structure. c, The export complex enters the nucleopore, 
where both CRM-1 and DDX3 interact with nucleoporins. d, Even after CRM-1 and Rev are released from the export com-
plex, DDX3 may still pull RNA through the complex by virtue of its processivity.Publish with BioMed Central    and   every 
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